Mn Services Vermogensbeheer B.V. Has $32.12 Million Stock Position in The Cigna Group (NYSE:CI)

Mn Services Vermogensbeheer B.V. raised its holdings in shares of The Cigna Group (NYSE:CI) by 1.7% during the fourth quarter, HoldingsChannel.com reports. The firm owned 116,300 shares of the health services provider’s stock after acquiring an additional 2,000 shares during the quarter. Mn Services Vermogensbeheer B.V.’s holdings in The Cigna Group were worth $32,115,000 at the end of the most recent quarter.

A number of other large investors also recently added to or reduced their stakes in CI. Prospera Private Wealth LLC acquired a new stake in shares of The Cigna Group in the 3rd quarter valued at approximately $37,000. Collier Financial acquired a new stake in The Cigna Group during the 4th quarter worth approximately $32,000. ORG Wealth Partners LLC acquired a new stake in The Cigna Group during the 4th quarter worth approximately $34,000. Harbor Capital Advisors Inc. acquired a new stake in The Cigna Group during the 3rd quarter worth approximately $45,000. Finally, Compagnie Lombard Odier SCmA acquired a new stake in The Cigna Group during the 4th quarter worth approximately $37,000. 86.99% of the stock is currently owned by institutional investors and hedge funds.

The Cigna Group Trading Down 2.8 %

Shares of The Cigna Group stock opened at $305.15 on Thursday. The Cigna Group has a 1 year low of $262.03 and a 1 year high of $370.83. The company has a debt-to-equity ratio of 0.70, a current ratio of 0.66 and a quick ratio of 0.72. The company has a market capitalization of $84.88 billion, a price-to-earnings ratio of 24.93, a P/E/G ratio of 0.98 and a beta of 0.54. The business has a fifty day simple moving average of $288.33 and a two-hundred day simple moving average of $318.98.

The Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, January 30th. The health services provider reported $6.64 EPS for the quarter, missing analysts’ consensus estimates of $7.84 by ($1.20). The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. During the same period last year, the company posted $6.79 earnings per share. Research analysts forecast that The Cigna Group will post 29.77 EPS for the current year.

The Cigna Group Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, March 20th. Investors of record on Wednesday, March 5th will be issued a $1.51 dividend. The ex-dividend date of this dividend is Wednesday, March 5th. This is a boost from The Cigna Group’s previous quarterly dividend of $1.40. This represents a $6.04 annualized dividend and a yield of 1.98%. The Cigna Group’s dividend payout ratio is presently 49.35%.

Analyst Upgrades and Downgrades

Several analysts have commented on the stock. Truist Financial dropped their target price on shares of The Cigna Group from $390.00 to $375.00 and set a “buy” rating on the stock in a report on Tuesday, February 4th. Deutsche Bank Aktiengesellschaft dropped their target price on shares of The Cigna Group from $398.00 to $394.00 and set a “buy” rating on the stock in a report on Monday, November 4th. Barclays dropped their target price on shares of The Cigna Group from $420.00 to $339.00 and set an “overweight” rating on the stock in a report on Friday, January 31st. UBS Group decreased their price target on shares of The Cigna Group from $410.00 to $390.00 and set a “buy” rating for the company in a research note on Monday, February 3rd. Finally, Royal Bank of Canada set a $355.00 price target on shares of The Cigna Group in a research note on Friday, January 31st. Two investment analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, The Cigna Group has a consensus rating of “Buy” and an average target price of $372.31.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.